IDEAL HEALTH, INC. v. Blechman

711 F. Supp. 2d 168, 2010 U.S. Dist. LEXIS 44951, 2010 WL 1904882
CourtDistrict Court, D. Massachusetts
DecidedMay 6, 2010
DocketCivil Action 09-10791-NMG
StatusPublished
Cited by1 cases

This text of 711 F. Supp. 2d 168 (IDEAL HEALTH, INC. v. Blechman) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IDEAL HEALTH, INC. v. Blechman, 711 F. Supp. 2d 168, 2010 U.S. Dist. LEXIS 44951, 2010 WL 1904882 (D. Mass. 2010).

Opinion

MEMORANDUM & ORDER

GORTON, District Judge.

Plaintiffs Ideal Health, Inc. (“Ideal”), Louis DeCaprio (“DeCaprio”), Scott Stan-wood, Todd Stanwood, UIX, LLC (“UIX”) and Infobroker, Inc. (“Infobroker”) brought suit for declaratory judgment against defendant Dean Blechman (“Blechman”) seeking 1) a declaration that Bleehman’s demands lack merit and 2) in the alternative, reformation of a certain shareholders’ agreement. After a related case filed by Blechman was transferred to this Court for consolidation, Blechman counterclaimed for 1) declaratory judgments in his favor, 2) the imposition of a constructive trust, 3) access to financial information and 4) recovery for unjust enrichment and “oppression of a minority shareholder”. Before the Court is plaintiffs’ motion to dismiss four of defendant’s counterclaims.

I. Background

A. Factual Background

This dispute provides a familiar scenario of a once-amicable business relationship *169 which, quite abruptly, turned bitterly contentious. Ideal was founded in 1997 by DeCaprio and Scott and Todd Stanwood (collectively, “the individual plaintiffs”). Ideal distributes and sells health care products, such as nutritional and vitamin supplements, through direct marketing. The individual plaintiffs are officers and directors of Ideal and UIX and Infobroker provide management services to it.

In March, 2007, Ideal hired Blechman to serve as Chief Executive Officer (“CEO”). Pursuant to Blechman’s employment agreement, he received a 10% stake in Ideal’s outstanding shares as well as a monthly salary and incentives. Because Blechman was allegedly hired to assist the company with its ailing financial condition, he was also eligible to receive additional equity if he secured financing or a capital investment on Ideal’s behalf.

Less than one year after he had been hired, the individual plaintiffs concluded that Blechman was not performing his duties as anticipated. In February, 2008, still on good terms, Blechman agreed to resign and the parties executed a Separation Agreement and General Release (“the Separation Agreement”). That agreement provided that Blechman would receive additional Ideal stock, bringing his total share to 13%. Section 2(c) also allowed him to earn more shares, up to the amount owned by each of the individual plaintiffs, for “financing secured, directly or indirectly” or

in the event that [he] brings an entity to [Ideal] for the purposes of entering into an acquisition agreement, and/or a change in controlling interest of [Ideal], ... upon closing of such a transaction

At about the time of his resignation, Ideal was beginning negotiations with representatives of Donald Trump (“Trump”) with respect to a significant business opportunity. Blechman alleges that he was solely responsible for introducing Trump to Ideal through his contact, Donald Kessler (“Kessler”). At first, the deal was to involve a transfer of stock to Trump but the parties ultimately settled on a license agreement. In March, 2009, TTN, LLC (“TTN”) (an entity owned and controlled by Ideal) entered into an agreement -with Trump through which Ideal gained rights to Trump’s likeness and trademarks and Trump agreed to promote its products personally. Ideal, in turn, re-branded itself as “The Trump Network” and updated all of its product lines accordingly. The deal has apparently been very lucrative for the plaintiffs who, according to Blechman, have already experienced a substantial increase in revenues.

Despite having resigned as CEO, Blechman was initially involved, at least tangentially, in the dealings with Trump. At some point during the negotiations, however, the relationship between Blechman and the plaintiffs turned sour. Blechman contends that plaintiffs made numerous promises, oral and in writing, before and after execution of the Separation Agreement, that he would become an equal shareholder in Ideal for his efforts with respect to the Trump deal. Plaintiffs, by contrast, deny that Blechman is responsible for their agreement with Trump and add that, in any event, the Separation Agreement bars Blechman’s claims to additional stock. In line with their respective positions, after the agreement with Trump was finalized, Blechman sought but was refused stock compensation from Ideal. The conflict quickly expanded to encompass additional disputes and, eventually, Blechman was denied access to any financial information of the company and from communicating with the plaintiffs.

B. Procedural History

Fearing either a lawsuit by Blechman or that disruption of their relationship with *170 Trump (or both), plaintiffs filed their complaint on May 14, 2009 seeking declaratory judgments that Blechman is not entitled to any relief. Less than one week later, Blechman filed suit in the New York Supreme Court for Suffolk County, similarly seeking declaratory and equitable relief against plaintiffs (“the New York case”). After that case was removed to the United States District Court for the Eastern District of New York, plaintiffs moved for a transfer of venue to this Court for consolidation. Because this action had been filed first and involved substantially similar issues, their motion was allowed and the case was transferred in November, 2009.

In the meantime, several motions had been filed in this action. After the New York case was transferred and assigned to another session of this Court, however, the parties entered into a stipulation 1) to dismiss voluntarily the transferred New York case, 2) to withdraw the motions pending in this action and 3) to allow Blechman to file an answer to the complaint in which he could reassert as counterclaims his claims from the New York case. Blechman filed an answer and counterclaims on March 2, 2010 and plaintiffs filed their motion to dismiss four of those counterclaims shortly thereafter. Without requesting leave of court, Blechman submitted a late opposition and a memorandum in excess of the page limit. The Court heard oral argument on the motion on April 16, 2010. 1

II. Analysis

A. Legal Standard

To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to “state a claim to relief that is plausible on its face.” Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007). In considering the merits of a motion to dismiss, the Court may look only to the facts alleged in the pleadings, documents attached as exhibits or incorporated by reference in the complaint and matters of which judicial notice can be taken. Nollet v. Justices of the Trial Court of Mass., 83 F.Supp.2d 204, 208 (D.Mass.2000) aff'd, 248 F.3d 1127 (1st Cir.2000). Furthermore, the Court must accept all factual allegations in the complaint as true and draw all reasonable inferences in the plaintiffs favor. Langadinos v. American Airlines, Inc., 199 F.3d 68, 69 (1st Cir.2000).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Formulatrix, Inc. v. Rigaku Automation, Inc.
344 F. Supp. 3d 410 (District of Columbia, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
711 F. Supp. 2d 168, 2010 U.S. Dist. LEXIS 44951, 2010 WL 1904882, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ideal-health-inc-v-blechman-mad-2010.